Induction of Th17 cell differentiation by B-1 cells

Frontiers in Immunology

Volumn 3, Issue SEP, 2012, Pages

  Wang, Yi ^a   Rothstein, Thomas L ^a,b  

^a Institute for Medical Research   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

B 1 cells; B 2 cells,Th17; CD44; CD86

Indexed keywords

EID: 84874235606     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00281     Document Type: Article

References (38)

1. Awasthi, A., and Kuchroo, V. K. (2009). Thl7 cells: from precursors to players in inflammation and infection. Int. Immunol. 2 f, 489-498.
2. Baumgarth, N. (2011). The double life of a B-l cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11, 34-46.
3. Baumgarth, N., Tung, J. W., and Herzenberg, L. A. (2005). Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26, 347-362.
4. Binder, C. J., and Silverman, G. J. (2005). Natural antibodies and the autoim-munity of atherosclerosis. Springer Semin. Immunopathol. 26, 385-404.
5. Forton, A. C, Petri, M. A., Goldman, D., and Sullivan, K. E. (2002). An osteopontin (SPP1) polymorphism is associated with systemic lupus ery-thematosus. Hum. Mutat. 19, 459.
6. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., and Fujiyama, Y. (2003). Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70.
7. Garrett-Sinha, L. A., John, S., and Gaffen, S. L. (2008). IL-17 and the Thl7 lineage in systemic lupus ery-thematosus. Curr. Opin. Rheumatol. 20,519-525.
8. Ghosn, E. E., Yang, Y, Tung, J., and Herzenberg, L. A. (2008). CDllb expression distinguishes sequential stages of peritoneal B-l development. Proc. Natl. Acad. Sci. U.S.A. 105, 5195-5200.
9. Greyner, H. J., Wiraszka, T., Zhang, L. S., Petroll, W. M., and Mummert, M. E. (2010). Inducible macropinocytosis of hyaluronaninB16-F10 melanoma cells. Matrix Biol. 29, 503-510.
10. Guan, H., Nagarkatti, P. S., and Nagarkatti, M. (2011). CD44 Reciprocally regulates the differentiation of encephalitogenic Thl/Thl7 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis. J Immunol. 186,6955-6964.
11. Hastings, W. D., Gurdak, S. M., Tumang, J. R., and Rothstein, T. L. (2006). CD5+/Mac-1- peritoneal B cells: a novel B cell subset that exhibits characteristics of B-l cells. Immunol. Lett. 105, 90-96.
12. Hathcock, K. S., Laszlo, G., Pucillo, C, Linsley, P., and Hodes, R. J. (1994). Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp. Med. 180, 631-640.
13. Herzenberg, L. A., and Tung, J. W. (2006). B cell lineages: documented at last! Nat Immunol. 7, 225-226.
14. Iizuka, J., Katagiri, Y., Tada, N., Murakami, M., Ikeda, T., Sato, M., Hirokawa, K., Okada, S., Hatano, M., Tokuhisa, T., and Uede, T. (1998). Introduction of an osteopontin gene confers the increase in Bl cell population and the production of anti-DNA autoantibodies. Lab. Invest. 78, 1523-1533.
15. Jansson, M., Panoutsakopoulou, V., Baker, J., Klein, L., and Cantor, H. (2002). Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J Immunol. 168,2096-2099.
16. Komiyama, Y, Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., and Iwakura, Y. (2006). IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573.
17. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. (2009). IL-17 and Thl7 Cells. Annu. Rev. Immunol. 27, 485-517.
18. Korn, T., Oukka, M., Kuchroo, V., and Bettelli, E. (2007). Thl7 cells: effector T cells with inflammatory properties. Semin. Immunol. 19, 362-371.
19. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y, Chen, Z., Yao, Z., Blank, R. B., Meylan, E, Siegel, R., Hennighausen, L., Shevach, E. M., and O'Shea J, J. (2007). Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26,371-381.
20. Lesley, J., Hyman, R., and Kincade, P. W. (1993). CD44 and its interaction with extracellular matrix. Adv. Immunol. 54,271-335.
21. Montecino-Rodriguez, E., Leathers, H., and Dorshkind, K. (2006). Identification of a B-l B cell-specified progenitor. Nat. Immunol. 7, 293-301.
22. Mucida, D., Park, Y, Kim, G., Tur-ovskaya, O., Scott, I., Kronenberg, M., and Cheroutre, H. (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260.
23. Murphy, T. P., Kolber, D. L, and Rothstein, T. L. (1990). Elevated expression of Pgp-1 (Ly-24) by murine peritoneal B lymphocytes. Eur. J. Immunol. 20,1137-1142.
24. Vlurugaiyan, G., Mittal, A., and Weiner, H. L. (2008). Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 181, 7480-7488.
25. Naor, D., Sionov, R. V., and Ish-Shalom, D. (1997). CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241-319.
26. Neufert, C, Becker, C, Wirtz, S., Fan-tini, M. C, Weigmann, B., Galle, P. R., and Neurath, M. F. (2007). IL-27 controls the development of inducible regulatory T cells and Thl7 cells via differential effects on STAT1. Eur. J. Immunol. 37,1809-1816.
27. Dboki, K., Ohno, T., Saito, H., and Nakae, S. (2008). Thl7 and allergy. Allergol. Int. 57, 121-134.
28. D'Garra, A., Chang, R., Go, N., Hastings, R., Haughton, G., and Howard, M. (1992). Ly-1 B (B-l) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22, 711-717.
29. Perosa, F, Prete, M., Racanelli, V., and Dammacco, F. (2010). CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. J Intern. Med. 267, 260-277.
30. Ponta, H., Sherman, L., and Herrlich, P. A. (2003). CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4, 33-45.
31. Megelman, M. H., DeGrendele, H. C, and Estess, P. (1999). Activation and interaction of CD44 and hyaluronan in immunological systems.J Leukoc. Bid. 66, 315-321.
32. Tumang, J. R., Holodick, N. E., Viz-conde, T. C, Kaku, H., Frances, R., and Rothstein, T. L. (2011). A CD25-positive population of activated Bl cells expresses LIFR and responds to LIE Front. Immunol 2:6. doi: 10.3389/fimmu.2011.00006
33. Xu, G., Nie, H., Li, N., Zheng, W., Zhang, D., Feng, G., Ni, L, Xu, R., Hong, J., and Zhang, J. Z. (2005). Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin. Invest. 115, 1060-1067.
34. Yumoto, K., Ishijima, M., Rittling, S. R., Tsuji, K., Tsuchiya, Y., Kon, S., Nifuji, A., Uede, T., Denhardt, D. T., and Noda, M. (2002). Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Nail. Acad. Sci. U.S.A. 99, 4556-4561.
35. Zhong, X., Gao, W., Degauque, N., Bai, C, Lu, Y, Kenny, J., Oukka, M., Strom, T. B., and Rothstein, T. L. (2007a). Reciprocal generation of Thl/Thl7 and T(reg) cells by Bl and B2 B cells. Eur. J. Immunol 37, 2400-2404.
36. Zhong, X., Tumang, J. R., Gao, W., Bai, C, and Rothstein, T. L. (2007b). PD-L2 expression extends beyond dendritic cells/macrophages to Bl cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol 37,2405-2410.
37. Zhong, X., Lau, S., Bai, C, Degauque, N., Holodick, N. E., Steven, S. J., Tumang, J. R., Gao, W., and Rothstein, T. L. (2009). A novel sub-population of Bl B cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum. 60,3734-3743.
38. Zhu, J., Yamane, H., and Paul, W. E. (2010). Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol 28,445-489